Skip to main content

Pfizer: Hold This Dow Stock For Its Dividends, But Don’t Buy At This Price

Moving forward the modest (albeit unspectacular) growth thesis and reasonable dividend are still intact. However, today’s valuation leaves a bit to be desired.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.